@article{schmitt2024_93100,
  title = {Evaluation of a Stepped Care Approach to Manage Depression and Diabetes Distress in Patients with Type 1 Diabetes and Type 2 Diabetes : Results of a Randomized Controlled Trial (ECCE HOMO Study)},
  author = {Schmitt, Andreas and Kulzer, Bernhard and Reimer, Andre and Herder, Christian and Roden, Michael and Haak, Thomas and Hermanns, Norbert},
  year = {2024},
  pages = {107-122},
  publisher = {Otto-Friedrich-Universität},
  address = {Bamberg},
  urn = {urn:nbn:de:bvb:473-irb-931006},
  url = {https://fis.uni-bamberg.de/handle/uniba/93100},
  language = {eng},
  abstract = {Introduction: Depression is a common and serious complication of diabetes. Treatment approaches addressing the specific demands of affected patients are scarce. 

Objective: The aim of this work was to test whether a stepped care approach for patients with diabetes and depression and/or diabetes distress yields greater depression reduction than treatment-as-usual. 

Methods: Two-hundred and sixty patients with diabetes and elevated depressive symptoms (CES-D ≥16) and/or elevated diabetes distress (PAID ≥40) were randomized to stepped care for depression or diabetes treatment-as-usual. The primary outcome was the rate of meaningful depression reduction at the 12-month follow-up according to the HAMD (score <9 or reduction by ≥50\%). Secondary outcomes were changes in depression scores (HAMD/CES-D), diabetes distress (PAID), diabetes acceptance (AADQ), well-being (WHO-5), quality of life (EQ-5D/SF-36), self-care behavior (SDSCA/DSMQ), HbA1c, and biomarkers of inflammation. 

Results: One-hundred and thirty-one individuals were assigned to stepped care and 129 to treatment-as-usual. Overall, 15.4\% were lost to follow-up. Meaningful depression reduction was observed in 80.2 versus 51.2\% in stepped care versus treatment-as-usual (p < 0.001, intention-to-treat analysis). Of the secondary measures, the HAMD (∆ –3.2, p < 0.001), WHO-5 (∆ 1.5, p = 0.007), and AADQ (∆ –1.0, p = 0.008) displayed significant treatment effects, while effects on CES-D (∆ –2.3, p = 0.065), PAID (∆ –3.5, p = 0.109), and SDSCA (∆ 0.20, p = 0.081) were not significantly different. Both groups showed comparable changes in EQ-5D/SF-36, DSMQ, HbA1c, and biomarkers of inflammation (all p ≥ 0.19). 

Conclusions: The stepped care approach improved depression, well-being, and acceptance. The results support that increasing treatment intensity on demand is effective and can help provide more optimal treatment. The inclusion of diabetes-specific interventions may be beneficial for patients with diabetes and elevated depression.},
  keywords = {Cognitive-behavioral therapy, Mood disorder, Depressive symptoms, Emotional distress, Stepped care approach}
}
